Bayerische Motoren Werke ADR (BMWYY)

Nutriband (NASDAQ: NTRB), a developer of transdermal pharmaceutical products, has entered into an Associate Partnership agreement with Charlotte FC to raise awareness of its flagship brands, including AI Tape and AVERSA. The company plans to leverage the partnership to enhance exposure for AI Tape, which is manufactured in the Charlotte region through its Pocono Pharmaceutical subsidiary. Nutriband also aims to spotlight its AVERSA platform, touted as a potential first-in-class abuse-deterrent patch for chronic pain management.

Sunshine Biopharma (NASDAQ: SBFM), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, has closed its previously announced registered direct offering with institutional investors of approximately $2.46 million shares of common stock and pre-funded warrants at a price of $2.07 per share of common stock. The company received aggregate gross proceeds of approximately $2.46 million from the offering, of which it intends to use the net for general corporate purposes and working capital. Aegis Capital Corp. acted as exclusive placement agent for the offering. Sichenzia Ross Ference Carmel LLP acted as counsel to the company, and Kaufman & Canoles, P.C. acted as counsel to Aegis.

ADHD, or attention deficit hyperactivity disorder, is usually diagnosed during one’s childhood, but more adults are being diagnosed with this condition. Experts have observed that among adults diagnosed with ADHD, the likelihood of developing dementia is heightened, but it hasn’t been clear why this is the case. Now a new study suggests a possible explanation for the increased possibility of dementia development among adult ADHD sufferers.

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company specializing in the development and commercialization of treatments for rare diseases and unmet medical needs, is making significant strides in its efforts to bring innovative therapies to patients with early-stage cutaneous T-cell lymphoma (“CTCL”). The company’s lead candidate, HyBryte(TM) (“SGX301”), has already demonstrated positive results in a prior phase 3 trial, and Soligenix is now conducting a phase 3 replication study to further validate its efficacy and safety ( https://ibn.fm/zdRnQ ). This development marks an important milestone in the company’s mission to address an urgent medical need in a condition with limited treatment options.

Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), will participate in the upcoming Jones Las Vegas Technology and Innovation Conference at The Venetian Resort. The April 8-9 event, organized by JonesTrading and supported by B2i Digital, provides a platform for direct engagement between innovative companies and institutional investors ( https://ibn.fm/fIKDc ).

Fifty 1 Labs (OTC: FITY), a forward-thinking leader in biotechnology and health innovation, today announced a groundbreaking achievement by its recently acquired subsidiary, Genetic Networks, in space-based biotechnology. The milestone stems from over a decade of space-based functional genomics from Dr. Corey Nislow’s laboratory, with the work highlighting the pivotal role of functional genomics in diverse aspects of human health and wellness. According to Dr. Nislow, the experiment findings have the potential to unlock new pathways for pharmaceutical development and human health in space exploration.

Cutaneous melanoma is the most aggressive skin cancer type and it is characterized by manifesting diverse mutations. Under normal circumstances, several of these mutations could be identified as threats by the immune system, but in this type of cancer, this doesn’t happen . Consequently, most patients are unresponsive to immunotherapy. This challenge has baffled oncology researchers for years.

Kairos Pharma (NYSE American: KAPA), a clinical-stage biopharmaceutical company, announced completion of the safety lead-in for its Phase 2 trial evaluating ENV105 in combination with apalutamide for metastatic, castration-resistant prostate cancer. The trial will now proceed with patient randomization to assess apalutamide alone versus the combination therapy. Safety and efficacy data from the lead-in phase are expected in the first half of 2025. The company is also validating biomarkers to identify patients most likely to benefit from ENV105 and continues enrollment at cancer centers in Los Angeles and Salt Lake City.

A recently published report indicates that the rate at which Medicare Advantage plans are growing is slowing down. The report was authored by HealthScape Advisors, a consulting company, together with Chartis, a healthcare advisory company.

Recent vehicle sales data from Europe reveals that Tesla, historically the world’s largest electric vehicle (EV) manufacturer, is losing ground to established automakers like Volkswagen and BMW Group. According to research platform JATO Dynamics, both BMW and Volkswagen sold more EVs than Tesla in the European market in February 2025, signaling trouble for the Texas-based automaker.

BMW has officially put the brakes on its plans to switch to solid-state batteries, citing high costs as the primary reason. While many automakers are racing to adopt this next-generation battery technology, BMW is taking a different approach. Instead of transitioning to solid-state batteries right away, the German carmaker is doubling down on improving lithium-ion batteries, which they believe still have untapped potential.

Paradise Car Keys sets the standard for mobile car locksmith services in the Gold Coast, delivering fast, reliable solutions for all vehicle brands, with specialized expertise in luxury models like BMW, Mercedes, Land Rover, and Porsche. Equipped with cutting-edge technology, the team offers key cutting, programming, ignition repairs, and transponder key services with unmatched precision.

Boris Mizhen has been championing the benefits of big data for some time. If more established brands successfully implement a more personalized experience alongside their aptitude for data management and analysis, impersonal advertising will be over.

Glioblastoma continues to be one of the most challenging cancers to treat as it resists even the latest innovations in immunotherapy. Now, a new study conducted by a team at the Sylvester Comprehensive Cancer Center at the University of Miami suggests that, when a specific protein is suppressed, an antiviral immune response increases the effectiveness of immune checkpoint inhibitors .

Not Your Basic Locksmith continues to set the benchmark for automotive locksmith in Arlington TX, and the wider DFW area. Specializing in both domestic and foreign vehicles, the company offers a wide array of solutions, including Mercedes car key replacement , ignition repair, smart key duplication, and fob programming, all delivered with precision and professionalism.

New research that appeared in the journal Oncotarget has opened the door to a new way to approach the treatment of oral ulcers induced by chemotherapy. This debilitating and painful side effect of cancer treatment lowers the quality of life of patients undergoing chemotherapy, but oral mucositis remains an unmet medical need.

Tesla, once the leader in the electric vehicle (EV) industry, is now struggling with falling sales . The situation has led to competitors like BMW to grow their share in the EV market. With a strong lineup of battery-electric vehicles (BEVs), new technology, and a strategy that includes different types of vehicles, BMW is positioning itself as a major player in the EV industry.

Boris Mizhen has been championing the benefits of big data for some time and believes once these more established brands successfully implement a more personalized experience alongside their aptitude for data management and analysis, the days of impersonal advertising will be over.

Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage immuno-oncology company that is pioneering proprietary technology designed to attack solid tumors, empowering the immune system to combat cancer. The company was featured in a recent article that discussed its platform, which utilizes antitumor virotherapies that selectively infect and kill cancer cells while stimulating the body’s immune response. Calidi’s pipeline includes three key therapies — RTNova, SuperNova and NeuroNova — that incorporate advanced technologies such as stem cells and antitumor viruses to target and destroy cancer cells. Calidi Biotherapeutics’ innovative therapies hold the potential to revolutionize cancer treatment by enhancing efficacy and stimulating immune response. For cancers such as glioblastoma multiforme (“GBM”), head & neck, triple-negative breast cancer (“TNBC”), sarcoma and lung cancer, where current treatments are often inadequate, Calidi’s approach offers promising new potential.

Redway ESS, a leading factory supplier and manufacturer of high-performance lithium iron phosphate (LiFePO4) batteries, proudly announces the launch of its 2025 Collection of LiFePO4 Car Starter Batteries . Designed to power leading automotive brands such as Ford, Toyota, Honda, BMW, Audi, and more, these cutting-edge lithium-ion starter batteries set new standards in performance, reliability, and sustainability.

Researchers studying brain waves have suggested that a new discovery they have made could hold the key to treating anxiety in people diagnosed with Parkinson’s disease . For a long time, DBS ( deep brain stimulation ) has been leveraged in the management of the physical symptoms linked to Parkinson’s, such as tremor, slowness and body stiffness. This new research suggests that DBS can take advantage of a specific brain wave and help treat anxiety in those with Parkinson’s disease.

The Woodlands, TX () March 3, 2025 -- A family-owned mechanic shop delivers comprehensive car care services near College Park Drive in The Woodlands, Texas.

Las Vegas, Nevada - February 27, 2025 - The manufacturer Mods4cars has permanently reduced the price of the SmartTV module for Volkswagen, Bentley and Skoda with immediate effect. The retrofittable TV in motion module now costs 99.00 Euros plus tax. It enables TV and DVD playback to be activated while driving. This allows the front passenger to operate the entertainment system and play DVDs on longer journeys.

Imperial Sportbikes, Denver’s leading motorcycle dealership, announces its diverse inventory of pre-owned motorcycles and comprehensive services tailored for enthusiasts.

Warrior Auto Glass (857-500-4422), an independent and locally-owned company based in central Massachusetts, announces support for the full line of Audi SUVs and sedans. The firm now offers OEM replacement parts, including sunroofs, in as little as one day or less.